48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Increasing evidence suggests that cholesterol plays a role in the pathophysiology of Alzheimer disease (AD). For instance, an elevated serum cholesterol level has been shown to be a risk factor for AD.

          Related collections

          Author and article information

          Journal
          Arch Neurol
          Archives of neurology
          American Medical Association (AMA)
          0003-9942
          0003-9942
          Oct 2000
          : 57
          : 10
          Affiliations
          [1 ] Department of Pharmacology, Loyola University Medical Center, Bldg 102, Room 3634, 2160 S First Ave, Maywood, IL 60153. bwolozi@luc.edu.
          Article
          noc00094
          10.1001/archneur.57.10.1439
          11030795
          b35376bb-b715-4c64-97d1-dd1ffab148e0
          History

          Comments

          Comment on this article